JP Morgan Call 435 GS 21.06.2024/ DE000JK8MMR3 /
2024-06-05 8:42:08 AM | Chg.+0.010 | Bid9:41:44 AM | Ask9:41:44 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.220EUR | +4.76% | 0.220 Bid Size: 20,000 |
0.230 Ask Size: 20,000 |
Goldman Sachs Group ... | 435.00 USD | 2024-06-21 | Call |
GlobeNewswire
06-04
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05-09
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04-11
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties
GlobeNewswire
02-23
New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Busines...
GlobeNewswire
2023-10-26
New to The Street's Leadership Series Airs Two Interviews, Sam Reese, CEO, Vistage Worldwide, Inc., ...